- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05357287
Closed Incisional Negative Pressure Wound Therapy in Post-surgical Wound Care of Patients With Periprosthetic Joint Infection
April 27, 2022 updated by: Chang Gung Memorial Hospital
In the proposed study, we will apply Prevena on the surgical wound right after closure of the wound in the operating theater. Prevena will be used for 7 days, unless there is ongoing infection or much wound drainage that requires debridement.
Most periprosthetic joint infections are from hematogenous origin. Hence, it is considered clean wound unless there is a discharging sinus.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sheng-Hsun Lee
- Phone Number: 2420 +886-3-3281200
- Email: 9002090@gmail.com
Study Locations
-
-
-
Taoyuan, Taiwan, 333
- Recruiting
- Chang Gung memorial hospital
-
Contact:
- Sheng-Hsun Lee
- Phone Number: 2420 +886-3-3281200
- Email: 9002090@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients with periprosthetic joint infection
- indicated for debridement surgery
- high risk for wound complication, including one of the followings: diabetes mellitus, use anticoagulants other than aspirin, current smoker, on immunomodulators or steroids, malnutrition, liver disease, renal failure, BMI > 35 kg/m2
Exclusion Criteria:
- previous flap surgery on the indexed joint
- younger than 18 years of age
- silver allergy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Prevena
|
We will apply Prevena on the surgical wound right after closure of the wound in the operating theater.
Prevena will be used for 7 days, unless there is ongoing infection or much wound drainage that requires debridement.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
wound complication
Time Frame: 12 weeks
|
Wound complication, including: Persistent wound drainage, blisters, hematoma, wound dehiscence, skin necrosis, suture abscess, cellulitis.
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 15, 2022
Primary Completion (Anticipated)
December 31, 2024
Study Completion (Anticipated)
December 31, 2024
Study Registration Dates
First Submitted
April 27, 2022
First Submitted That Met QC Criteria
April 27, 2022
First Posted (Actual)
May 2, 2022
Study Record Updates
Last Update Posted (Actual)
May 2, 2022
Last Update Submitted That Met QC Criteria
April 27, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- XMRPG3L1721
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wound Heal
-
Danni FengNot yet recruiting
-
Melaka Manipal Medical CollegeCompleted
-
Basaksehir Cam & Sakura Şehir HospitalIstanbul Kent UniversityEnrolling by invitation
-
AiViva BioPharma, Inc.Completed
-
RWTH Aachen UniversityWithdrawn
-
Cook Biotech IncorporatedRecruitingWounds and Injuries | Surgical Wound | Wound Heal | WoundUnited Kingdom
-
Shanghai Ninth People's Hospital Affiliated to...Recruiting
-
University of NebraskaRecruiting
-
Salma NabilRecruiting
-
Nanfang Hospital, Southern Medical UniversityCompleted
Clinical Trials on PREVENA incision management system
-
University of North Carolina, Chapel HillKinetic Concepts, Inc.TerminatedComplications; Arthroplasty, Infection or Inflammation | Wound ComplicationUnited States
-
State University of New York at Buffalo3MCompleted
-
St. James's Hospital, IrelandNot yet recruitingIleostomy - Stoma | Colostomy Stoma | Stoma Site InfectionIreland
-
Northwell HealthTerminatedSurgical Procedure, UnspecifiedUnited States
-
University of Calgary3MCompletedCoronary Artery Disease | Wound Complication | Complication of Coronary Artery Bypass GraftCanada
-
3MRecruitingAbdominal Surgery | Orthopedic Surgery | Vascular Surgery | Cardiovascular SurgeryUnited States
-
University of Vermont Medical CenterBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; Dartmouth-Hitchcock... and other collaboratorsUnknownPeripheral Artery Disease | Claudication | Critical Limb IschemiaUnited States
-
Memorial Sloan Kettering Cancer Center3M; Miami Cancer InstituteCompletedNegative-Pressure Wound TherapyUnited States
-
3MKCI Europe Holding B.V.TerminatedWound Infection | Surgical Site Occurences After SternotomyGermany, Netherlands, Austria
-
Masonic Cancer Center, University of MinnesotaCompletedObesity | Postoperative Complications | Gynecologic NeoplasmsUnited States